International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
The Reform Institute Thomas Mann of the Brookings Institution, and Norman Ornstein of the American Enterprise Institute. The Reform Institute The Reform Institute is an American non-partisan, not-for-profit think tank based in Alexandria, VA that describes itself as centrist oriented. According to its website it is an "organization working to strengthen the foundations of our democracy and build a resilient society. The Institute formulates and advocates valuable, solutions-based reform in vital areas of public policy." The major policy areas the institute focuses on are energy and environmental policy, homeland and national security, economic opportunity and competitiveness, immigration reform, and governance and election reform.